Christopher E. Nelson
Assistant Professor, The Twenty-First Century Professorship in Biomedical Engineering
College of Engineering
Our lab develops biologically inspired strategies for controlled drug and gene delivery for gene therapy and regenerative medicine.
Delivery of genome editing technologies – As therapeutics, genome editing technologies hold great promise. The challenge is safe and efficient delivery to diseased tissues in the patient. We are adapting viral and non-viral delivery vehicles and assessing safety and efficiency in preclinical models of disease.
Gene regulation in regenerative medicine and wound healing – Changes to gene expression in chronic disease delaying or preventing tissue regeneration or restoration. Targeted control of gene expression can illuminate new drug targets.
- Postdoctoral Fellow, Duke University
- Ph.D., Vanderbilt University
- B.S., University of Arkansas
- Controlled Release Society Postdoctoral Fellowship
- The Hartwell Foundation Postdoctoral Fellowship
- Pathway to Independence Award - K99/R00 (NIH/NIBIB)